ENDOTAK RELIANCE, (Defibrillation Leads)
FDA premarket approval P910073/S142 · decided 2017-09-20
Approval details
- PMA number
- P910073
- Supplement
- S142
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- ENDOTAK RELIANCE, (Defibrillation Leads)
- Generic name
- Implantable cardioverter defibrillator (non-CRT)
- Applicant
- Boston Scientific
- Date received
- 2017-05-26
- Decision date
- 2017-09-20
- Days to decision
- 117 days
- Decision code
- APPR
- Product code
- LWS
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- St Paul, MN
- Statement
- Approval to label a subset of the market released devices as ImageReady MR Conditional Defibrillation System.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.